153 filings
Page 2 of 8
6-K
4r8l6afc
15 Jun 23
Altamira Therapeutics Announces IND Clearance by U.S. FDA for AM-125 in Acute Vestibular Syndrome
4:30pm
6-K
s2zj57m 6h
30 May 23
Notice of the Annual General Meeting of Shareholders
8:00am
6-K
4tkto hec9
26 May 23
Report of Foreign Private Issuer
5:29pm
6-K
w70l87es2 kv2tz
16 May 23
Altamira Therapeutics Provides Business Update, Reports FY 2022 Financial Results
4:30pm
6-K
aqsddmg v6s
2 May 23
Convertible Loan Agreement
8:30am
6-K
kvrw0jtjc5y7rtmxc19w
18 Apr 23
Report of Foreign Private Issuer
8:00am
6-K
fm29n4wx jy3i4
13 Apr 23
Report of Foreign Private Issuer
9:05am
6-K
frt411r
3 Apr 23
Report of Foreign Private Issuer
3:00pm
6-K
qozgofbiko6c ktkn
9 Mar 23
Current Report
4:30pm
6-K
mdt8o
17 Feb 23
Report of Foreign Private Issuer
4:30pm
6-K
zcmdbf508stbt
27 Jan 23
Report of Foreign Private Issuer
8:50am
6-K
p4pl32 wdvn
24 Jan 23
Altamira Therapeutics Provides Update on Clinical Trials with Bentrio
9:00am
6-K
hc4t7kjq
19 Dec 22
Altamira Therapeutics Provides Year-End 2022 Business Update
4:31pm
6-K
cxx7wdrs2fuvoi90
5 Dec 22
Report of Foreign Private Issuer
4:30pm
6-K
1lf1 npamno0g7s
30 Nov 22
Report of Foreign Private Issuer
9:00am
6-K
bru0hok4yidw 113
9 Nov 22
Report of Foreign Private Issuer
9:00am
6-K
lv7odvnjd4ofglv38f8
24 Oct 22
Share Purchase Agreement
4:30pm
6-K
66ifr
24 Oct 22
Report of Foreign Private Issuer
9:00am
6-K
8bytg4i
29 Sep 22
Report of Foreign Private Issuer
4:30pm
6-K
yjpul kg491d
12 Sep 22
Report of Foreign Private Issuer
4:22pm